Synthesis of Phosphorodiamidate Morpholino Oligonucleotides (PMOs) Using Staudinger Reduction as a Deblocking Condition and Its Usefulness for Orthogonal Conjugation in Bi- and Trifunctionalized PMOs

Abstract

The synthesis of short phosphorodiamidate morpholino oligonucleotides (PMOs) has been successfully achieved using azidoaryl carbamate protected chlorophosphoramidate monomers. The deprotection step carried out in a neutral medium with triphenylphosphine-based reagents avoids the need for chlorinated solvents. This method uses a meticulously tailored combination of resin support, solvents, deblocking agents, and coupling reagents to ensure efficient synthesis. Additionally, the azidoaryl carbamate protecting group has been adapted as an orthogonal protection, enabling the development of bi- and trifunctionalized PMOs for bioconjugation. These advancements are expected to broaden the potential applications of PMOs in biomedical research.

Key words

antisense agents - oligonucleotides - protecting groups - conjugation - solid-phase synthesis

Publication History

Received: 29 June 2024

Accepted after revision: 12 August 2024

Accepted Manuscript online:
12 August 2024

Article published online:
11 September 2024

• References and Notes

• 1a Summerton JE. Biochim. Biophys. Acta 1999; 1489: 141
• 1b Summerton JE, Weller D. Antisense Nucleic Acid Drug Dev. 1997; 7: 187
• 1c Summerton JE. Methods Mol. Biol. 2017; 1565: 1
• 2a Shen X, Corey DR. Nucleic Acids Res. 2018; 46: 1584
• 2b Moulton JD. Curr. Protoc. Nucleic Acid Chem. 2017; 68: 4301
• 3a Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Nat. Rev. Dis. Primers 2021; 7: 13
• 3b Gupta S, Sharma SN, Kundu J, Pattanayak S, Sinha S. J. Biosci. 2023; 48: 38
• 3c Egli M, Manoharan M. Nucleic Acids Res. 2023; 51: 2529
• 4a Li C, Callahan AJ, Simon MD, Totaro KA, Mijalis AJ, Phadke K.-S, Zhang G, Hartrampf N, Schissel CK, Zhou M, Zong H, Hanson GJ, Loas A, Pohl NL. B, Verhoeven DE, Pentelute BL. Nat. Commun. 2021; 12: 4396
• 4b Paul S, Caruthers MH. Molecules 2023; 28: 5380
• 5a Kundu J, Ghosh A, Ghosh U, Das A, Nagar D, Pattanayak S, Ghose A, Sinha S. J. Org. Chem. 2022; 87: 9466
• 5b Kundu J, Ghosh U, Ghosh A, Pattanayak S, Das A, Sinha S. Curr. Protoc. Nucleic Acid Chem. 2023; 3: 1
• 6 Darrah K, Wesalo J, Lukasak B, Tsang M, Chen JK, Deiters A. J. Am. Chem. Soc. 2021; 143: 18665
• 7 Saxon E, Bertozzi CR. Science 2000; 287: 2007
• 8a Poulou E, Hackenberger CP. R. Isr. J. Chem. 2023; 63: e202200057
• 8b Hang HC, Yu C, Kato DL, Bertozzi CR. Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 14846
• 8c Nieto-García O, Jaffee MB, Mühlberg M, Hackenberger CP. R. The Staudinger Ligation, Wiley-VCH; Weinheim: 2017: 97
• 8d Kohn M, Breinbauer R. Angew. Chem. Int. Ed. 2004; 43: 3106
• 8e Wesalo JS, Luo J, Morihiro K, Liu J, Deiters A. ChemBioChem 2020; 21: 141
• 8f Heiss TK, Dorn RS, Prescher JA. Chem. Rev. 2021; 121: 6802
• 8g Bednarek C, Wehl I, Jung N, Schepers U, Bräse S. Chem. Rev. 2020; 120: 4301
• 8h Kasper M.-A, Glanz M, Oder A, Schmieder P, von Kries JP, Hackenberger CP. R. Chem. Sci. 2019; 10: 6322
• 9a Pattanayak S, Paul S, Nandi B, Sinha S. Nucleosides Nucleotides Nucleic Acids 2012; 31: 763
• 9b Pattanayak S, Sinha S. Tetrahedron Lett. 2012; 53: 6714
• 9c Das A, Ghosh A, Sinha S. Org. Biomol. Chem. 2023;  21: 1242
• 10a Lukasak B, Morihiro K, Deiters A. Sci. Rep. 2019; 9: 1470
• 10b Huang R, Li CH, Cao-Milán R, He LD, Makabenta JM, Zhang X, Yu L, Rotello VM. J. Am. Chem. Soc. 2020; 142: 10723
• 10c Yanagisawa T, Kuratani M, Seki E, Hino N, Sakamoto K, Yokoyama S. Cell Chem. Biol. 2019; 26: 936
• 11 Ghosh U, Gupta S, Sinha S. Bioconjugate Chem. 2023; 34: 174
• 12 Das A, Gupta S, Shaw P, Sinha S. Mol. Pharm. 2024; 21: 1256
• 13 Li YF. J. Drug. Discov. Develop. and Deliv. 2016; 3: 1021